These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 22937035)

  • 21. Identification of a 6-cytokine prognostic signature in patients with primary glioblastoma harboring M2 microglia/macrophage phenotype relevance.
    Cai J; Zhang W; Yang P; Wang Y; Li M; Zhang C; Wang Z; Hu H; Liu Y; Li Q; Wen J; Sun B; Wang X; Jiang T; Jiang C
    PLoS One; 2015; 10(5):e0126022. PubMed ID: 25978454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allograft inflammatory factor-1 defines a distinct subset of infiltrating macrophages/microglial cells in rat and human gliomas.
    Deininger MH; Seid K; Engel S; Meyermann R; Schluesener HJ
    Acta Neuropathol; 2000 Dec; 100(6):673-80. PubMed ID: 11078219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of Cathepsin X in Glioblastoma: Interplay with γ-Enolase and the Effects of Selective Cathepsin X Inhibitors.
    Majc B; Habič A; Novak M; Rotter A; Porčnik A; Mlakar J; Župunski V; Pečar Fonović U; Knez D; Zidar N; Gobec S; Kos J; Lah Turnšek T; Pišlar A; Breznik B
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
    Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
    Liang Y; Bollen AW; Aldape KD; Gupta N
    BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells.
    Cai L; Kirchleitner SV; Zhao D; Li M; Tonn JC; Glass R; Kälin RE
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression site of P2RY12 in residential microglial cells in astrocytomas correlates with M1 and M2 marker expression and tumor grade.
    Zhu C; Kros JM; van der Weiden M; Zheng P; Cheng C; Mustafa DA
    Acta Neuropathol Commun; 2017 Jan; 5(1):4. PubMed ID: 28073370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liposomal TriCurin, A Synergistic Combination of Curcumin, Epicatechin Gallate and Resveratrol, Repolarizes Tumor-Associated Microglia/Macrophages, and Eliminates Glioblastoma (GBM) and GBM Stem Cells.
    Mukherjee S; Baidoo JNE; Sampat S; Mancuso A; David L; Cohen LS; Zhou S; Banerjee P
    Molecules; 2018 Jan; 23(1):. PubMed ID: 29346317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gain.
    Geisenberger C; Mock A; Warta R; Rapp C; Schwager C; Korshunov A; Nied AK; Capper D; Brors B; Jungk C; Jones D; Collins VP; Ichimura K; Bäcklund LM; Schnabel E; Mittelbron M; Lahrmann B; Zheng S; Verhaak RG; Grabe N; Pfister SM; Hartmann C; von Deimling A; Debus J; Unterberg A; Abdollahi A; Herold-Mende C
    Acta Neuropathol; 2015 Sep; 130(3):419-34. PubMed ID: 25931051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploiting Microglial Functions for the Treatment of Glioblastoma.
    Dello Russo C; Lisi L; Tentori L; Navarra P; Graziani G; Combs CK
    Curr Cancer Drug Targets; 2017; 17(3):267-281. PubMed ID: 27528361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In search of druggable targets for GBM amino acid metabolism.
    Panosyan EH; Lin HJ; Koster J; Lasky JL
    BMC Cancer; 2017 Feb; 17(1):162. PubMed ID: 28245795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumors.
    Kaffes I; Szulzewsky F; Chen Z; Herting CJ; Gabanic B; Velázquez Vega JE; Shelton J; Switchenko JM; Ross JL; McSwain LF; Huse JT; Westermark B; Nelander S; Forsberg-Nilsson K; Uhrbom L; Maturi NP; Cimino PJ; Holland EC; Kettenmann H; Brennan CW; Brat DJ; Hambardzumyan D
    Oncoimmunology; 2019; 8(11):e1655360. PubMed ID: 31646100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MCP-1 and MIP-3α Secreted from Necrotic Cell-Treated Glioblastoma Cells Promote Migration/Infiltration of Microglia.
    Jung Y; Ahn SH; Park H; Park SH; Choi K; Choi C; Kang JL; Choi YH
    Cell Physiol Biochem; 2018; 48(3):1332-1346. PubMed ID: 30048972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis.
    Rickman DS; Bobek MP; Misek DE; Kuick R; Blaivas M; Kurnit DM; Taylor J; Hanash SM
    Cancer Res; 2001 Sep; 61(18):6885-91. PubMed ID: 11559565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM.
    Ge H; Mu L; Jin L; Yang C; Chang YE; Long Y; DeLeon G; Deleyrolle L; Mitchell DA; Kubilis PS; Lu D; Qi J; Gu Y; Lin Z; Huang J
    Int J Cancer; 2017 Oct; 141(7):1434-1444. PubMed ID: 28612394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear Respiratory Factor 1 (NRF1) Transcriptional Activity-Driven Gene Signature Association with Severity of Astrocytoma and Poor Prognosis of Glioblastoma.
    Bhawe K; Felty Q; Yoo C; Ehtesham NZ; Hasnain SE; Singh VP; Mohapatra I; Roy D
    Mol Neurobiol; 2020 Sep; 57(9):3827-3845. PubMed ID: 32594352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tenascin-C: a novel candidate marker for cancer stem cells in glioblastoma identified by tissue microarrays.
    Nie S; Gurrea M; Zhu J; Thakolwiboon S; Heth JA; Muraszko KM; Fan X; Lubman DM
    J Proteome Res; 2015 Feb; 14(2):814-22. PubMed ID: 25469866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of survival-related genes of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma multiforme.
    Ruano Y; Mollejo M; Camacho FI; Rodríguez de Lope A; Fiaño C; Ribalta T; Martínez P; Hernández-Moneo JL; Meléndez B
    Cancer; 2008 Apr; 112(7):1575-84. PubMed ID: 18260157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential expression of a novel voltage gated potassium channel--Kv 1.5 in astrocytomas and its impact on prognosis in glioblastoma.
    Arvind S; Arivazhagan A; Santosh V; Chandramouli BA
    Br J Neurosurg; 2012 Feb; 26(1):16-20. PubMed ID: 21707241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ham56-immunoreactive macrophages in untreated infiltrating gliomas.
    Cummings TJ; Hulette CM; Bigner SH; Riggins GJ; McLendon RE
    Arch Pathol Lab Med; 2001 May; 125(5):637-41. PubMed ID: 11300934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.